Healthcare Innovation CSR News

Novartis and Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic Alongside Bill & Melinda Gates Foundation

Collaboration to address product development and scale up challenges posed by current pandemic
Press Release

BASEL, Switzerland, March 26, 2020/3BL Media/ - Today, Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. The industry brings a range of assets, resources, and expertise needed to identify effective and scalable solutions to the pandemic that is affecting billions worldwide.

Coronavirus and the Multifaceted Role of Measurement

by Jay Alexander, CTO at Keysight Technologies
Summary: 

From medical professionals to electrical engineers and computer scientists, we're seeing experts across a wide range of disciplines stepping up to face the challenges that coronavirus presents to our society. The coronavirus detection research happening at the Missouri University of Science and Technology is a great example, and measurement is playing a significant role.

Blog

From medical professionals to electrical engineers and computer scientists, we're seeing experts across a wide range of disciplines stepping up to face the challenges that coronavirus presents to our society. The coronavirus detection research happening at the Missouri University of Science and Technology is a great example, and measurement is playing a significant role.

American Express Is Matching Donations to Feeding America up to $1M to Feed Communities Impacted by COVID-19 when Card Members Use Membership Rewards® Points Toward Their Donations

New Program is Part of Company’s $5 Million Commitment to Support COVID-19 Relief Efforts
Press Release

NEW YORK, March 24, 2020 /3BL Media/  American Express is continuing its support of organizations combatting COVID-19 with the launch of a donation matching program to help feed local communities impacted in the U.S. When U.S.

The 2020 Call for Code Global Challenge Takes On COVID-19

By Willie Tejada
Article

Nearly one month ago, together with Creator David Clark Cause and in partnership with United Nations Human Rights and the Linux Foundation, we announced climate change as the theme for the 2020 Call for Code Global Challenge. In that brief period, much has changed. COVID-19 (Coronavirus) has spread across the world with unprecedented effect and now has the potential to become the greatest crisis of modern times.

IBM Helps Bring Supercomputers Into the Global Fight Against COVID-19

By Dario Gil, Director of IBM Research
Article

At IBM, I have the privilege of working with colleagues who have dedicated their lives and careers to advancing science and creating innovative technology that can be a force for progress in the world. Since the start of the COVID-19 pandemic we have been working closely with governments in the U.S.

New York Times Magazine Explores Lab’s Work With Gene Drives

Article

CRB-designed facility supports work to remap mosquito genes in fight against infectious disease

The highly complex and scientific battle to contain, treat and one day cure mosquito-borne disease is being waged on groundbreaking fronts. One of them is at a laboratory at the University of California, San Diego, where scientists are working obsessively to re-map arthropod genetics and, ultimately, flip the script on infectious illnesses.

Innovative Sodexo and University of Rhode Island Partnership Prepares Registered Dietitian Candidates for 2024 Exam Requirements

Collaboration Supports Career Development and Boosts Participation in Top-Ranking URI Online Master’s of Dietetics Program
Press Release

GAITHERSBURG, Md. and SOUTH KINGSTOWN, R.I., March 11, 2020 /3BL Media/ - Sodexo, one of the largest employers of registered dietitians globally, partners with University of Rhode Island to boost participation in URI master’s of dietetics program.

Medtronic Perspective: Collaborating to Improve Global Health Access

Article

Despite the unprecedented advances in healthcare, the benefits of progress are not being shared equally among all populations. Many treatments and services that have become the standard of care in some areas remain inaccessible to others. The result is inequality in diagnosis and treatment — and most importantly, in health outcomes — for the most prevalent diseases.

Read more.

The Arbor Day Foundation Recognizes Inaugural Class of Tree Campus Healthcare Facilities

Sixteen hospitals across the country are recognized for their leadership in wellness and community engagement through trees
Press Release

LINCOLN, Neb., March 2, 2020 /3BL Media/ – The Arbor Day Foundation today recognized sixteen hospitals across the United States as the first-ever Tree Campus Healthcare facilities. The healthcare institutions earned this recognition by demonstrating a commitment to improving community wellness through tree planting, education, and community engagement.

International Research Partnership and EDCTP to Invest €44m in Next-generation Antimalarials to Combat Drug-resistant Malaria in Africa

Summary: 
  • EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million.
     
  • The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new medicines for both severe and uncomplicated malaria, designed to combat emerging artemisinin resistance.
     
  • The projects will include development of the first new malaria treatment for babies under 5 kg, a new fast-acting medicine for the treatment of severe malaria, and new combinations to treat drug-resistant uncomplicated malaria.
Press Release
  • EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million.
     
  • The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new medicines for both severe and uncomplicated malaria, designed to combat emerging artemisinin resistance.
     
  • The projects will include development of the first new malaria treatment for babies under 5 kg, a new fast-acting medicine for the treatment of severe malaria, and new combinations to treat drug-resistant uncomplicated malaria.

Pages

Subscribe to Healthcare Innovation